Prognosis in Palliative Therapy - a Prospective Study on Survival Prognostication in Advanced Stage Cancer Patients
18 Years
N/A
Both
Cancer
Trial Information
Prognosis in Palliative Therapy - a Prospective Study on Survival Prognostication in Advanced Stage Cancer Patients
- At presentation a clinical survival estimate is obtained in each patient.
- Survival is also estimated using published prognostic scores in palliative care.
- Prognostic scores based on blood samples, general symptoms, complaints, and performance
status are calculated and validated, respectively
- Each patient completes questionnaires on psychological distress
- Survival estimates are limited to 6 months.
- Each patient is followed for at least 6 months.
Inclusion Criteria:
- oncologic disease confirmed
- incurable locally advanced or metastatic disease
- palliative treatment intended
- age > 18
- able to understand the study protocol
- able to complete the forms with assistance if necessary
Exclusion Criteria:
- therapy with curative intent
- regular clinical follow-up visit without disease progression
- ongoing therapy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Survival
Outcome Time Frame:
6 months
Safety Issue:
No
Principal Investigator
Stephan Gripp, Dr.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Universtity Hospital Duesseldorf, Radiation Oncology Department
Authority:
Germany: Ethics Commission
Study ID:
Pro-08
NCT ID:
NCT00871520
Start Date:
April 2008
Completion Date:
December 2014
Related Keywords:
- Cancer
- Palliative Care
- Predictive Value of Tests
- Prospective Studies
- Survival Analysis
- Survival prediction
Name | Location |
|---|
